Jason Gardner - Title: President and Chief Executive Officer, Director at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: President and Chief Executive Officer, Director
Stock Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jason Gardner since 11/23/2023

Holdings reported by Jason Gardner for Dianthus Therapeutics, Inc. /DE/

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 359K $4.31M $12.00 Nov 30, 2022 By P.S. Gardner Irrevocable Trust
Common Stock 293K $3.52M $12.00 Nov 30, 2022 By J.P. Gardner Irrevocable Trust
Common Stock 293K $3.51M $12.00 Nov 30, 2022 Direct

Transactions reported by Jason Gardner for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.